Literature DB >> 3937733

Evaluation of a bioluminescence assay for rapid antimicrobial susceptibility testing of mycobacteria.

B Beckers, H R Lang, D Schimke, A Lammers.   

Abstract

The antimicrobial susceptibility of Mycobacterium tuberculosis H37Rv and 17 clinical isolates of the same species was determined using a bioluminescence assay to measure adenosine triphosphate (ATP) produced by bacteria in the broth dilution test performed in Dubos-Tween-albumin broth. The results were compared with those obtained with the standard dilution proportional method performed on Löwenstein-Jensen medium. The drugs tested were streptomycin, rifampin, ethambutol and isoniazid. There was high correlation between bacterial count and ATP concentration in a liquid culture of Mycobacterium tuberculosis H37Rv (r = 0.993); when several cultures of the same strain were assayed after different incubation periods the correlation was somewhat lower (r = 0.846). Addition of tuberculostatic drugs in inhibitory concentrations resulted in a reduction in the ATP concentration as compared to control assays without drugs. Results of susceptibility tests performed by the two methods agreed in 66 out of 68 assays. Differences in the inhibitory concentrations determined by the two methods were due to differences in the methods. Whereas the standard method requires 3 to 4 weeks of incubation, results of the bioluminescence assay were available after five days of incubation. Automation of the assay for routine use is possible.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3937733     DOI: 10.1007/bf02013394

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN: 0722-2211            Impact factor:   3.267


  11 in total

1.  Experimental observations on the antimycobacterial activity of rifampin.

Authors:  T F Hobby GL LENERT; J Maier-Engallena
Journal:  Proc Soc Exp Biol Med       Date:  1969-06

2.  Rapid drug susceptibility testing of M. tuberculosis H 37 Rv with bioluminescence.

Authors:  B Beckers; H R Lang; D Schimke
Journal:  Prax Klin Pneumol       Date:  1983-10

3.  Evaluation of rapid radiometric method for drug susceptibility testing of Mycobacterium tuberculosis.

Authors:  S H Siddiqi; J P Libonati; G Middlebrook
Journal:  J Clin Microbiol       Date:  1981-05       Impact factor: 5.948

4.  Automatable radiometric detection of growth of Mycobacterium tuberculosis in selective media.

Authors:  G Middlebrook; Z Reggiardo; W D Tigertt
Journal:  Am Rev Respir Dis       Date:  1977-06

5.  Rapid radiometric susceptibility testing of Mycobacterium tuberculosis.

Authors:  J A Kertcher; M F Chen; P Charache; C C Hwangbo; E E Camargo; P A McIntyre; H N Wagner
Journal:  Am Rev Respir Dis       Date:  1978-04

6.  A rapid radiometric method for determining the sensitivity of clinical isolates of Mycobacterium tuberculosis to several chemotherapeutic agents.

Authors:  R E McDaniel; M K Abensohn; D R Spoon; G S Kobayashi; G Medoff; J J Marr
Journal:  J Lab Clin Med       Date:  1977-04

7.  MYCOBACTERIA: LABORATORY METHODS FOR TESTING DRUG SENSITIVITY AND RESISTANCE.

Authors:  G CANETTI; S FROMAN; J GROSSET; P HAUDUROY; M LANGEROVA; H T MAHLER; G MEISSNER; D A MITCHISON; L SULA
Journal:  Bull World Health Organ       Date:  1963       Impact factor: 9.408

8.  [On the possibility of a rapid method for sensitivity testing of mycobacteria by determination of H3-uracil incorporation (author's transl)].

Authors:  M Kunze; T Sanabria de Isele; A Vogt
Journal:  Zentralbl Bakteriol Orig A       Date:  1977-09

9.  Rapid drug-susceptibility testing of Mycobacterium tuberculosis.

Authors:  D E Snider; R C Good; J O Kilburn; L F Laskowski; R H Lusk; J J Marr; Z Reggiardo; G Middlebrook
Journal:  Am Rev Respir Dis       Date:  1981-04

10.  Antimycobacterial activity of rifampin under in vitro and simulated in vivo conditions.

Authors:  K D Stottmeier; G P Kubica; C L Woodley
Journal:  Appl Microbiol       Date:  1969-06
View more
  12 in total

1.  Bioluminescence screening in vitro (Bio-Siv) assays for high-volume antimycobacterial drug discovery.

Authors:  T M Arain; A E Resconi; M J Hickey; C K Stover
Journal:  Antimicrob Agents Chemother       Date:  1996-06       Impact factor: 5.191

2.  An Overview on Novel Microbial Determination Methods in Pharmaceutical and Food Quality Control.

Authors:  Mahboob Nemati; Aliasghar Hamidi; Solmaz Maleki Dizaj; Vahid Javaherzadeh; Farzaneh Lotfipour
Journal:  Adv Pharm Bull       Date:  2016-09-25

3.  Rapid susceptibility testing of Mycobacterium tuberculosis by bioluminescence assay of mycobacterial ATP.

Authors:  L E Nilsson; S E Hoffner; S Anséhn
Journal:  Antimicrob Agents Chemother       Date:  1988-08       Impact factor: 5.191

4.  Nutritional cues control Pseudomonas aeruginosa multicellular behavior in cystic fibrosis sputum.

Authors:  Kelli L Palmer; Lindsay M Aye; Marvin Whiteley
Journal:  J Bacteriol       Date:  2007-09-14       Impact factor: 3.490

5.  Novel antibiotic susceptibility tests by the ATP-bioluminescence method using filamentous cell treatment.

Authors:  N Hattori; M O Nakajima; K O'Hara; T Sawai
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

6.  Comparison of techniques for antimicrobial susceptibility testing of mycobacteria.

Authors:  D I Limb; P F Wheat; R C Spencer; G S Harris; A B Rayner; B Watt
Journal:  J Clin Pathol       Date:  1993-05       Impact factor: 3.411

7.  In vitro activities of 2,2'-bipyridyl analogs against Mycobacterium leprae.

Authors:  A M Dhople; M A Ibanez; A A Dhople
Journal:  Antimicrob Agents Chemother       Date:  1994-12       Impact factor: 5.191

8.  In vitro activity of levofloxacin, singly and in combination with rifamycin analogs, against Mycobacterium leprae.

Authors:  A M Dhople; M A Ibanez
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

Review 9.  Methods for in vitro evaluating antimicrobial activity: A review.

Authors:  Mounyr Balouiri; Moulay Sadiki; Saad Koraichi Ibnsouda
Journal:  J Pharm Anal       Date:  2015-12-02

Review 10.  Current Screening Methodologies in Drug Discovery for Selected Human Diseases.

Authors:  Olga Maria Lage; María C Ramos; Rita Calisto; Eduarda Almeida; Vitor Vasconcelos; Francisca Vicente
Journal:  Mar Drugs       Date:  2018-08-14       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.